Massive Bio, a world-renowned provider of personalized oncology solutions, is set to showcase its groundbreaking GPT4 AI chatbots - AskFiona AI and DrArturo. These innovative, AI-driven solutions will redefine cancer care, establishing new paradigms in patient and provider engagement and global oncological research. Massive Bio's ChatGPT-powered platform lies at the heart of the transformation in clinical trials. Incorporating AskFiona AI and DrArturo AI will transcend the capabilities of Massive Bio's existing SYNERGY-AI Clinical Trial Matching Solution, thereby heralding a new epoch in personalized oncology solutions.
A board of physicians make expert recommendations on your best course of treatment.
We coordinate with your local physician and facilitate the process of implementing the recommendations locally.
We track your progress and are with you every step of the way.
You’ll have access to the Massive Bio social media community of team members and other patients who’ve gone through the process.
Patient - United States of America - February 2021
Patient – United States of America – September 2020
Patient – United States of America – June 2020
Patient – United States of America – January 2019
Patient - United States of America - March 2018
Patient - United States of America - February 2017